Amalgamated Bank’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Amalgamated Bank’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,316	Closed	-$231K	–	1447
2016 Q1	$231K	Buy	4,316 +381	+10%	+$28.1K	0.02%	1051
2015 Q4	$445K	Sell	3,935 -359	-8%	-$39.5K	0.05%	504
2015 Q3	$505K	Buy	4,294 +54	+1%	+$7.05K	0.05%	501
2015 Q2	$328K	Buy	+4,240	New	+$278K	0.03%	902

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Amalgamated Bank's ANAC Position: Q2 2016 in Review

Amalgamated Bank sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,316 shares — an estimated $231K sold.

Amalgamated Bank first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $505K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Amalgamated Bank reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Amalgamated Bank sold 4,316 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $231K.
Amalgamated Bank first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
Amalgamated Bank's ANACOR PHARMACEUTICALS INC COM position peaked at $505K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Amalgamated Bank's 13F filing for Q2 2016, filed 16 Aug 2016.